Riskpilot← Back to searchSign inGet full accessVisionisti Oy
OYActiveY-tunnus 2478909-3Tulikivimylly 7Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2012— employees
Revenue 2025
EUR 2K
EBITDA margin
30.3%
+131% vs 2024
Equity ratio
8.8%
Financial strength
Net profit 2025
EUR -16K
+8% vs 2024
| Revenue | EUR 2K | — |
| EBITDA | EUR 605 | +131% |
| Net profit | EUR -16K | +8% |
| Total assets | EUR 71K | -4% |
| Equity | EUR 6K | -32% |
| Employees | — | — |
Legal name
Visionisti Oy
Y-tunnus number
2478909-3
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. toukokuuta 2012
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääke- ja kemianteollisuuden, terveydenhoidon, kuntoutuksen, yleisen hyvinvoinnin sekä näiden alojen tuotteiden kaupan ja maahantuonnin samoin kuin muu näihin aloihin liittyvän liiketoimminan harjoittaminen. Yhtiö voi omistaa ja hallita kiinteistöjä ja arvopapereita sekä muita rahoitusinstrumentteja sekä käydä niillä kauppaa.
Address
Tulikivimylly 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 | 0 | −2 | 0 | 2 |
| Staff expenses | — | — | −0 | −0 | −0 |
| EBITDA | 12 | −5 | −4 | −2 | 1 |
| Depreciation & amort. | −14 | −14 | −15 | −16 | −17 |
| EBIT | −2 | −20 | −19 | −18 | −16 |
| Net financials | −0 | −0 | 0 | 0 | 0 |
| Profit before tax | −2 | −20 | −19 | −18 | −16 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 | −20 | −19 | −18 | −16 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 105 | 93 | 82 | 74 | 71 |
| Equity | −3 | 2 | 5 | 9 | 6 |
| Long-term debt | 103 | 91 | 77 | 0 | 0 |
| Short-term debt | 5 | 1 | 77 | 65 | 65 |
| Total debt | 108 | 92 | 77 | 65 | 65 |
EBITDA margin
30.3%
This company
15.8%
Market median
+92% vs market
20212025
Equity ratio
8.8%
This company
38.2%
Market median
-77% vs market
20212025
Return on equity
-256.1%
This company
18.4%
Market median
-1492% vs market
20212025
Net profit margin
-806.1%
This company
8.1%
Market median
-10052% vs market
20212025
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20212025
Debt / equity
10.32×
This company
0.62×
Market median
-1565% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TJ Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Visionisti Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Juhani Kangastupa | Chief Executive Officer | 0 companies |
| Päivikki Irmeli Kangastupa | Board of Directors | 0 companies |
| Tommi Tapani Järvinen | Board of Directors | 0 companies |
| Tero Tapani Rinne | Board of Directors | 0 companies |